Loading...
Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study)
CONTEXT: In postmenopausal osteoporosis, combining denosumab and teriparatide increases hip and spine bone mineral density more than either monotherapy. OBJECTIVE: The objective of the study was to determine the effects of 2 years of combination therapy on bone microarchitecture and estimated streng...
Na minha lista:
| Udgivet i: | J Clin Endocrinol Metab |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Endocrine Society
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4870854/ https://ncbi.nlm.nih.gov/pubmed/26964731 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2016-1160 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|